{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/scrotal-pain-swelling/management/epididymo-orchitis/","result":{"pageContext":{"chapter":{"id":"879d1089-3597-5302-880f-78ba41e6d6fe","slug":"epididymo-orchitis","fullItemName":"Scenario: Epididymo-orchitis","depth":2,"htmlHeader":"<!-- begin field 559091db-f292-4c5e-bac7-71e1c01f6ccb --><h2>Scenario: Epididymo-orchitis</h2><!-- end field 559091db-f292-4c5e-bac7-71e1c01f6ccb -->","summary":"Covers the management of epididymo-orchitis, epididymitis, and orchitis.","htmlStringContent":"<!-- begin item 41e50b52-84cc-4c36-9d5b-592c458fef12 --><!-- begin field cf01eb2b-46fd-41f9-9bcb-acbc01598b86 --><p>From birth onwards (Male).</p><!-- end field cf01eb2b-46fd-41f9-9bcb-acbc01598b86 --><!-- end item 41e50b52-84cc-4c36-9d5b-592c458fef12 -->","topic":{"id":"c0e9e90f-75d6-5d49-8c70-e9215d1cdd77","topicId":"e3f85b52-b1cf-4983-bdbb-c554bdc48453","topicName":"Scrotal pain and swelling","slug":"scrotal-pain-swelling","lastRevised":"Last revised in September 2020","chapters":[{"id":"55887dd8-613a-5092-b969-3ff37334b54d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e5a5fb24-6fb1-5945-9423-1a9af6d25500","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"048453e3-33cc-5bcb-9d4b-70feac30e75e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3a109b4d-6a7d-592c-8538-565bccebbd06","slug":"changes","fullItemName":"Changes"},{"id":"fbd52de6-27c8-50d9-b8e1-4db58c832fc3","slug":"update","fullItemName":"Update"}]},{"id":"c3871411-4575-5802-a45f-8372d7ad3d2c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c6b6dd51-1df4-5856-8e4b-2798eeb52585","slug":"goals","fullItemName":"Goals"},{"id":"5ecda96f-813a-5f90-8c6a-e6e845c3af2a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"79b5caf2-ead9-5abd-bf02-555c8a0c9aa5","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0c223ad9-7e1e-5561-8336-004562db25cc","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b763d533-1a50-585a-8880-54a78504ccd6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"09c3c61b-4551-50e4-9e35-f2de369756bb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c73436d8-1cf1-53ce-a668-65e38c13c03e","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"85b37453-8227-55d3-bfa2-7dafc06842ca","slug":"causes","fullItemName":"Causes"}]},{"id":"1ba46ed5-8a8d-5e11-8ba7-20ebd6df46b5","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ae6fdb3f-942f-50dc-aa71-cd8a13ffe0b9","slug":"assessment","fullItemName":"Assessment"},{"id":"9a2fb908-f850-5555-a587-9a0b0c1cfb53","slug":"when-to-ultrasound","fullItemName":"When to ultrasound"}]},{"id":"487587a8-13ea-5ad1-b569-493005013fa2","fullItemName":"Management","slug":"management","subChapters":[{"id":"7f9387b0-6d86-598c-a940-77237c793ec5","slug":"testicular-torsion","fullItemName":"Scenario: Testicular torsion"},{"id":"ad4a1f46-53e1-57f2-a757-9612fea24f25","slug":"testicular-cancer","fullItemName":"Scenario: Testicular cancer"},{"id":"ec6aca82-4b93-5b89-9c9b-eaeb0c63017d","slug":"squamous-cell-carcinoma-of-the-scrotum","fullItemName":"Scenario: Squamous cell carcinoma of the scrotum"},{"id":"cdff5d21-685c-56d4-8b67-8edaa6a63d2c","slug":"inguinal-hernia","fullItemName":"Scenario: Inguinal hernia"},{"id":"879d1089-3597-5302-880f-78ba41e6d6fe","slug":"epididymo-orchitis","fullItemName":"Scenario: Epididymo-orchitis"},{"id":"90aa499c-9532-5e4e-abb7-541f4f07f451","slug":"haematocele","fullItemName":"Scenario: Haematocele"},{"id":"657d0eeb-2719-5016-99b3-cdc341f4b1e2","slug":"epididymal-cyst-spermatocele","fullItemName":"Scenario: Epididymal cyst/spermatocele"},{"id":"3c3ad5fd-d565-5f54-87cc-f33c2fd5e99e","slug":"varicocele","fullItemName":"Scenario: Varicocele"},{"id":"42465c6c-cc4f-563f-b631-849c7330a5fb","slug":"hydrocele","fullItemName":"Scenario: Hydrocele"}]},{"id":"54eca506-beb4-5707-9686-73ad11c9500d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9b67969f-fc26-5cac-b61d-05a832131aad","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c7a76cc1-2479-5219-948a-de6fd1df394c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5bb65ffb-d88a-57bd-afa4-34a94eadaeb1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bd50fb8b-903a-5e6d-a9ae-4e8f6ae9b3f8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"33cc43a6-9f1d-5245-968d-5e59759b5cb9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81104ab4-a95d-5ecf-bdcc-24e0a1b8a3cd","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2dc88556-8fc4-51f7-8e4e-0590678dd6fb","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"487587a8-13ea-5ad1-b569-493005013fa2","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"3030be08-1055-5d60-ab60-3d847f1ab5ec","slug":"man-or-adolescent-boy","fullItemName":"Man or adolescent boy","depth":3,"htmlHeader":"<!-- begin field 59d84e15-635d-41cb-92cf-d6c0fc59b36a --><h3>How should I manage a man or adolescent boy with suspected epididymo-orchitis?</h3><!-- end field 59d84e15-635d-41cb-92cf-d6c0fc59b36a -->","summary":null,"htmlStringContent":"<!-- begin item a59edfb1-a750-4dc6-9cf6-a85a0619e059 --><!-- begin field f7772fe2-8b94-461f-a517-36df59a142b7 --><ul><li><strong>If symptoms are severe or the man or boy is very unwell, </strong>consider admitting to hospital, particularly if he has diabetes or is immunocompromised.</li><li><strong>Ideally, refer for same-day or next-day assessment by a sexual health specialist </strong>(if mumps orchitis is not diagnosed).</li><li><strong>If urgent referral to a sexual health specialist is not possible, identify the most likely causative organism based on risk factors.</strong><ul><li>Sexually transmitted infection:<ul><li>Age less than 35 years.</li><li>More than one sexual partner in the past 12 months.</li><li>Urethral discharge.</li></ul></li><li>Gonorrhoeal infection:<ul><li>Previous gonorrhoea infection.</li><li>Known contact of a person with gonorrhoea.</li><li>Purulent urethral discharge.</li><li>Men who have sex with men.</li><li>Black ethnicity.</li></ul></li><li>Enteric organisms associated with lower urinary tract infections:<ul><li>Age 35 years or older.</li><li>Low risk sexual history.</li><li>History of penetrative anal intercourse.</li><li>Recent urological instrumentation or catheterization.</li></ul></li></ul></li><li>For information on testing for sexually transmitted infections, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/gonorrhoea/\">Gonorrhoea</a> and <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia&nbsp;</a>.</li><li>Also consider testing for trichomoniasis, HIV, hepatitis, and syphilis.<ul><li>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/trichomoniasis/\">Trichomoniasis</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>.</li></ul></li><li>Consider other causes, such as mumps orchitis (parotid swelling may be present), Behçet's syndrome, tuberculosis, or the medication, amiodarone. <ul><li>If mumps orchitis is suspected, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/mumps/\">Mumps</a>.</li><li>If amiodarone is suspected, reduce the dose or stop treatment. </li></ul></li><li><strong>If epididymo-orchitis is thought to be due any sexually transmitted organism, including gonorrhoea:</strong><ul><li>Treat without waiting for test results with ceftriaxone 1g intramuscular (IM) injection as a single dose, <em>plus </em>doxycycline 100 mg orally twice daily for 10–14 days. <br><ul><li>If cephalosporins and/or tetracyclines are contraindicated, treat with ofloxacin 200 mg orally twice daily for 14 days. </li></ul></li><li>Refer to a sexual health specialist for follow up and contact tracing. If this is not possible, arrange follow up in primary care at the end of treatment.</li><li>Advise the man or adolescent boy not to have any sexual contact during treatment and until his sexual partners have been traced and treated.</li></ul></li><li><strong>If epididymitis is thought to be due to chlamydia or other non-gonococcal organism:</strong><ul><li>Treat orally with doxycycline 100 mg orally twice daily for 10–14 days, or ofloxacin 200 mg orally twice daily for 14 days.</li></ul></li><li><strong>If epididymitis is thought to be due to sexually transmitted chlamydia and gonorrhoea <em>and/or </em>enteric organisms:  </strong><ul><li>Consider treating with 1g ceftriaxone IM plus ofloxacin 200 mg orally twice daily for 10 days.</li></ul></li><li><strong>If epididymo-orchitis is thought to be due to an enteric organism </strong>(for example, <em>Escherichia coli</em>):<ul><li>Treat without waiting for test results with ofloxacin 200 mg orally twice daily for 14 days, or levofloxacin 500 mg orally once daily for 10 days. <ul><li>Avoid quinolones in people with a history of tendon disorders related to quinolones, or a history of seizures or conditions that predispose to seizures.</li><li>Quinolones — increased risk of convulsions with an NSAID. Concurrent use should be avoided in people with epilepsy or with conditions that predispose to seizures. </li></ul></li><li>If a quinolone is contraindicated, treat with co-amoxiclav 500/125 mg three times daily for 10 days. Avoid in people with hepatic impairment, or a history of hepatic dysfunction associated with co-amoxiclav (risk of cholestatic jaundice).</li></ul></li><li><strong>Advise:</strong><ul><li>Bed rest, scrotal elevation (such as with supportive underwear), and analgesia until signs of local inflammation or fever have resolved.</li><li>If symptoms worsen, or do not begin to improve within 3 days, return for reassessment.</li></ul></li></ul><!-- end field f7772fe2-8b94-461f-a517-36df59a142b7 --><!-- end item a59edfb1-a750-4dc6-9cf6-a85a0619e059 -->","subChapters":[{"id":"cf240c1e-e0dc-57a0-9faa-e92951c12232","slug":"basis-for-recommendation-923","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field dbcbee6a-1e54-4e4a-b606-85837e47cce9 --><h4>Basis for recommendation</h4><!-- end field dbcbee6a-1e54-4e4a-b606-85837e47cce9 -->","summary":null,"htmlStringContent":"<!-- begin item 9237877d-61b3-4506-9653-8cd51010bdca --><!-- begin field 52b15d89-4382-4aac-bef9-a0cc74e85a7c --><p>These recommendations are based on the International Union against Sexually Transmitted Infections (IUSTI) <em>European guideline on the management of epididymo-orchitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">IUSTI, 2016</a>], the British Association for Sexual Health and HIV (BASHH) <em>National guideline for the management of epididymo-orchitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2019</a>], <em>National guideline for the management of infection with </em><em><em>Chlamydia trachomatis</em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2015</a>], <em>National guideline for the management of gonorrhoea in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2011</a>], the European Association of Urology (EAU) guideline <em>Urological infections</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">EAU, 2016b</a>], the Royal College of General Practitioners (RCGP) and the British Association for Sexual Health and HIV (BASHH) guideline <em>Sexually transmitted infections in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">RCGP, 2013</a>], expert opinion from the British Society for Antimicrobial Chemotherapy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">British Society for Antimicrobial Chemotherapy, 2010</a>] and the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BNF 72, 2016</a>].</p><h5>Dose of ceftriaxone</h5><ul><li>BASHH recommends a dose of 1g ceftriaxone IM for treatment of epididymo-orchitis when a sexually transmitted pathogen is suspected [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2019</a>].</li><li>However, the IUSTI and the EAU recommend a dose of ceftriaxone 500 mg for men suspected of having sexually transmitted epididymo-orchitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">IUSTI, 2016</a>], the World Health Organization (WHO) recommends a dose of ceftriaxone 250 mg for treatment of gonorrhoea, but acknowledges that local antimicrobial susceptibility and guidelines should dictate the choice of treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">WHO, 2016</a>], and the BMJ best practice guide also recommends a dose of ceftriaxone 250 mg for men suspected of having sexually transmitted epididymo-orchitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BMJ, 2016c</a>].</li></ul><h5>Consider admitting if symptoms are severe or the man or boy is very unwell, particularly if diabetic or immunocompromised</h5><ul><li>This recommendation is based on the expert opinion of a CKS reviewer.</li></ul><h5>Use of quinolones in children </h5><ul><li>Quinolones are generally not recommended in children and growing adolescents because they cause arthropathy in the weight-bearing joints of immature animals, however the significance of this effect in humans is uncertain. They may be used where the benefit is considered to outweigh the potential risks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BNF for Children, 2017</a>].</li><li>The consensus view of BSAC is that ciprofloxacin is safe for use in children, and that the benefits of use outweigh any risks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">British Society for Antimicrobial Chemotherapy, 2010</a>].</li><li>The recommendation to use co-amoxiclav as an alternative to ciprofloxacin/quinolones in the treatment of epididymo-orchitis thought to be due to enteric organisms is based on expert opinion from a personal communication from BSAC [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">British Society for Antimicrobial Chemotherapy, 2010</a>] and the BASHH guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2019</a>].</li></ul><!-- end field 52b15d89-4382-4aac-bef9-a0cc74e85a7c --><!-- end item 9237877d-61b3-4506-9653-8cd51010bdca -->","subChapters":[]}]},{"id":"0d3070de-492c-58f0-bd7d-4cd07a05cdc7","slug":"follow-up","fullItemName":"Follow up","depth":3,"htmlHeader":"<!-- begin field bffc3aba-f645-4c40-afc2-1c501a7c7b96 --><h3>How should I follow up a man or adolescent boy with epididymo-orchitis?</h3><!-- end field bffc3aba-f645-4c40-afc2-1c501a7c7b96 -->","summary":null,"htmlStringContent":"<!-- begin item 172032c0-52e2-4df2-a46f-4e37336e078f --><!-- begin field 3f2856d6-f7ce-42c1-bb73-1387363b1572 --><ul><li><strong>If swelling has worsened or has not started to improve within 3 days of commencing antibiotics, </strong>reassess, and consider a change of antibiotics according to laboratory results (no causative organism is found in 30–40% of men with epididymitis), or consider admission to urology.<ul><li>Further follow up is recommended at 2 weeks to assess compliance with treatment, partner notification, and improvement of symptoms.</li></ul></li><li><strong>If swelling persists after antibiotic treatment is completed, </strong>refer for an urgent outpatient appointment with a urologist to exclude underlying testicular cancer.</li><li><strong>If a urinary tract infection is confirmed, </strong>refer to a urologist to investigate for an underlying structural abnormality or urinary tract obstruction. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-men/\">Urinary tract infection (lower) - men</a> for more information.</li><li><strong>If a sexually transmitted infection is confirmed, </strong>see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia - uncomplicated genital</a>, <a class=\"topic-reference external-reference\" href=\"/topics/gonorrhoea/\">Gonorrhoea</a>, <a class=\"topic-reference external-reference\" href=\"/topics/trichomoniasis/\">Trichomoniasis</a>, or <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>, and see the section on <a class=\"topic-reference external-reference\" href=\"/topics/urethritis-male/diagnosis/\">Diagnosis</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urethritis-male/\">Urethritis - male</a>.</li></ul><!-- end field 3f2856d6-f7ce-42c1-bb73-1387363b1572 --><!-- end item 172032c0-52e2-4df2-a46f-4e37336e078f -->","subChapters":[{"id":"e6b777b9-fd23-5689-9371-37612762b2ad","slug":"basis-for-recommendation-cd8","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 810192c5-3e3f-4cd7-a3d7-5ce63ce07a3f --><h4>Basis for recommendation</h4><!-- end field 810192c5-3e3f-4cd7-a3d7-5ce63ce07a3f -->","summary":null,"htmlStringContent":"<!-- begin item cd8b0e4e-cf5d-46d4-b349-73428a9273f7 --><!-- begin field 73fed034-004b-4ccd-9a24-4275496f3ae2 --><p>These recommendations are based on the British Association for Sexual Health and HIV (BASHH) <em>National guideline for the management of epididymo-orchiti</em>s [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2010</a>], the Royal College of General Practitioners and the British Association for Sexual Health and HIV guideline <em>Sexually transmitted infections in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">RCGP, 2013</a>] and expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">Riddick, 1998</a>], [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">Ludwig, 2008</a>]. </p><ul><li>Anatomical or functional abnormalities of the urinary tract are common in men infected with Gram negative enteric organisms (for example <em>Escherichia coli</em>), and further investigation of the urinary tract should be considered in all such patients, but especially in those older than 50 years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2010</a>].</li><li>The recommendation to refer urgently to exclude underlying testicular cancer if swelling does not improve is derived from a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">Riddick, 1998</a>].</li><li>No causative organism is found in 30–40% of men with epididymitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">Ludwig, 2008</a>].</li></ul><!-- end field 73fed034-004b-4ccd-9a24-4275496f3ae2 --><!-- end item cd8b0e4e-cf5d-46d4-b349-73428a9273f7 -->","subChapters":[]}]},{"id":"6128ebab-7434-5e34-a1db-595adb817ed4","slug":"pre-pubertal-boy","fullItemName":"Pre-pubertal boy","depth":3,"htmlHeader":"<!-- begin field 3ec8cef8-3562-4695-a9d0-ffdc0419dc50 --><h3>How should I manage a pre-pubertal boy with suspected epididymo-orchitis?</h3><!-- end field 3ec8cef8-3562-4695-a9d0-ffdc0419dc50 -->","summary":null,"htmlStringContent":"<!-- begin item ee51c994-e077-447d-8512-45ad756ab009 --><!-- begin field bbe2fc5b-efef-48e9-8a52-b6f13c6d9dbb --><ul><li><strong>Admit if systemically very unwell.</strong></li><li><strong>If mumps orchitis is suspected </strong>(because of the presence of parotid swelling), see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/mumps/\">Mumps</a>.</li><li><strong>Obtain a mid-stream urine sample </strong>for dipstick, microscopy, and culture.</li><li><strong>If urine dipstick or microscopy and culture indicate a urinary tract infection:</strong><ul><li>Seek specialist advice on the choice of antibiotic, dose, and duration of treatment.</li><li>Referral to a paediatric specialist may be required for further investigations — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-children/\">Urinary tract infection - children</a>.</li></ul></li><li><strong>If a urinary tract infection is not identified</strong>, antibiotic treatment, although often started, is not indicated.<ul><li>Epididymitis is usually self-limiting and with supportive therapy (such as minimal physical activity and analgesics) resolves without complications. </li></ul></li></ul><!-- end field bbe2fc5b-efef-48e9-8a52-b6f13c6d9dbb --><!-- end item ee51c994-e077-447d-8512-45ad756ab009 -->","subChapters":[{"id":"0f4afde6-95ea-51e1-99b0-b149f04a221a","slug":"basis-for-recommendation-8d1","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2eb841e8-0cd3-4784-a0db-065fd80d387b --><h4>Basis for recommendation</h4><!-- end field 2eb841e8-0cd3-4784-a0db-065fd80d387b -->","summary":null,"htmlStringContent":"<!-- begin item 8d110c7b-0688-4d8f-a560-110eb8d10305 --><!-- begin field 2467ad96-5246-4796-af74-36131f463465 --><p>These recommendations are based on European Association of Urology (EAU) guidelines Paediatric urology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">EAU, 2016c</a>], and <em>Urological infections</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">EAU, 2016b</a>], the British Association for Sexual Health and HIV (BASHH) <em>N</em><em>ational guideline for the management of epididymo-orchitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2010</a>] and the British National Formulary.</p><h5>Admit if systemically unwell</h5><ul><li>This recommendation is based on what CKS considers good clinical practice. </li></ul><h5>Specialist advice </h5><ul><li>CKS recommends seeking specialist advice about the treatment of pre-pubertal boys with epididymo-orchitis in association with a UTI as there are no guidelines or primary evidence to guide the choice, dose, and duration of antibiotics specifically in this age group, and because antibiotics recommended for adults with epididymo-orchitis are not normally recommended in children.<ul><li>Guidelines on urological infections from the European Association of Urology recommend quinolones for 10–14 days [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">EAU, 2016b</a>]. However, these guidelines do not differentiate between pre-pubertal children and adolescents or men.</li><li>A BASHH national guideline for the management of epididymo-orchitis only makes recommendations for adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BASHH, 2010</a>].</li><li>The British National Formulary (BNF) and the BNF for Children state that quinolones are generally not recommended in children and growing adolescents because they cause arthropathy in the weight-bearing joints of immature animals, but that the significance of this effect in humans is uncertain. However, they may be used where the benefit is considered to outweigh the potential risks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/scrotal-pain-swelling/references/\">BNF for Children, 2017</a>].</li></ul></li></ul><!-- end field 2467ad96-5246-4796-af74-36131f463465 --><!-- end item 8d110c7b-0688-4d8f-a560-110eb8d10305 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}